Molecular epidemiology and increasing macrolide resistance of Bordetella pertussis isolates in Guangzhou, China. [PDF]
Mai Q +17 more
europepmc +1 more source
Molecular epidemiology and genomic features of Bordetella pertussis in Tianjin, China, 2023. [PDF]
Lu X +9 more
europepmc +1 more source
Genomic surveillance reveals global spread of macrolide-resistant <i>Bordetella pertussis</i> linked to vaccine changes. [PDF]
Xu Z +7 more
europepmc +1 more source
Draft genome sequence of <i>Bordetella pertussis</i> PS21, a circulating clinical isolate from India. [PDF]
Irulappan M +7 more
europepmc +1 more source
Author Correction: Respiratory immunization using antibiotic-inactivated Bordetella pertussis confers T cell-mediated protection against nasal infection in mice. [PDF]
Jazayeri SD +3 more
europepmc +1 more source
Limited response of primary nasal epithelial cells to <i>Bordetella pertussis</i> infection. [PDF]
Zmuda M +5 more
europepmc +1 more source
Seroprevalence of <i>Bordetella pertussis</i> in patients with COPD in a UK cohort. [PDF]
Richardson H +5 more
europepmc +1 more source
A model based evaluation of the 1996-7 pertussis epidemic in the Netherlands [PDF]
Boven, M., van +3 more
core +2 more sources
Comparing Respiratory Illness Surveillance Case Definitions to Detect Bordetella pertussis in Children Aged <5 Years With Respiratory Illness in South Africa, 2017-2023. [PDF]
Bishop K +15 more
europepmc +1 more source
An endogenous human peptide derived from α<sub>1</sub>-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin. [PDF]
Lietz S +14 more
europepmc +1 more source

